No. | Drug Name | Decision |
1) | Propafenone 150mg Tablet (Rytmonorm) | Agreed to accept as Special Formulary. |
2) | Flecainide 100mg Tablet (Tambocor) | Rejected as Special Formulary. Propafenone was accepted as Special Formulary for the same indication. |
3) | Deferasirox 90mg Tablet Deferasirox 360mg Tablet (Exjade) | Rejected as Standard Formulary. Suggest requestor to apply for extra funding from Jawatankuasa Pengurusan Kewangan dan Akaun (JPKA) for additional subsidy for five patients. |
4) | Flurbiprofen 4mg Patch (Acustop Cataplasma) | Rejected as Special Formulary. Availability of Diclofenac Gel and Ketoprofen Gel in the UMMC formulary and readily available in retail pharmacies. |
5) | Paroxetine 25mg CR Tablet (Seroxat) | Agree to delete from the UMMC formulary. To use generic option as first choice and was agreed by Psychiatric Team to switch to Apo-Paroxetine 20mg Tablet. |
6) | Montelukast 4mg Tablet (Singulair) | Agree to delete from the UMMC formulary. Slow movement and stocks were expired. Availability of Montelukast 4mg Granules in the UMMC formulary. |
7) | Telbivudine 600mg Tablet (Sebivo) | Agree to delete from the UMMC formulary. Company discontinuation. |
8) | Tinzaparin 4500units Injection (Innohep) | Agree to delete from the UMMC formulary. Company discontinuation. |
9) | Vitamin B (B1, B2, B6) Injection (Becolim) | Agree to delete from the UMMC formulary. Company discontinuation. Availability of Vitamin B and C Injection in the UMMC formulary. |
10) | Olodaterol 2.5mcg Inhalation Solution (Striverdi Respimat) | Agree to delete from the UMMC formulary. Company discontinuation. Availability of Spiriva Respimat and Spiolto Respimat in the UMMC formulary. |
11) | Oxybutinin 5mg Tablet (Voxytane) | Agree to delete from the UMMC formulary. Company discontinuation and was agreed by Peadiatric Surgery Team. |
12) | Dulaglutide 0.75mg Injection Dulaglutide 1.5mg Injection (Trulicity) | Rejected as Special Formulary. Dulaglutide’s Cardiovascular Outcome Trial (CVOT) published: Dulaglutide reduced cardiovascular outcomes in patients with or without previous cardiovascular disease. Costs more than Liraglutide 1.2mg once daily (with CVOT) and Exenatide 2mg once weekly. |
